Compare Sana Biotechnology Inc (SANA) vs Direxion Daily 20 Year Treasury Bull 3X Shares (TMF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Direxion Daily 20 Year Treasury Bull 3X Shares — how do they compare? Sana Biotechnology Inc trades at $3.79 (market cap $1.13B), while Direxion Daily 20 Year Treasury Bull 3X Shares trades at $30.85. The key difference: Sana Biotechnology Inc is trading nearer its 52-week high, Direxion Daily 20 Year Treasury Bull 3X Shares nearer its low. Which is the better fit depends on your goals.
| SANA | TMF | |
|---|---|---|
Market Cap | $1.13B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $5.92 | $44.14 |
52-Week Low | $2.68 | $30.59 |
Enterprise Value | $1.05B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SANA Biotechnology trades at $3.77, up 4.43% on the day, with a bullish technical signal from moving averages and oscillators despite overbought RSI readings. The company reported a net loss of $244.17 million in 2025, with negative cash flow from operations, but analyst sentiment is strong with 82% buy ratings. Recent news highlights clinical data presentations and a $9.50 consensus price target from brokerages as of July 30, 2026.
The outlook hinges on clinical progress in engineered cell therapies, with upside potential from positive trial outcomes, but risks include persistent cash burn and execution challenges. Investors face high volatility given the pre-revenue biotech profile and dependence on financing activities to sustain operations.
TMF, a leveraged ETF tracking long-term Treasury bonds, trades at $30.72 with a slight 0.26% daily gain. Technical indicators are predominantly bearish, with moving averages signaling sell pressure and oscillators neutral. The stock faces resistance and support near $31. Recent news highlights significant long-term losses due to leverage decay, emphasizing its high-risk nature.
The outlook for TMF remains speculative, driven by interest rate volatility. Opportunities exist for short-term traders betting on bond market rebounds, but risks include daily leverage reset losses and macroeconomic sensitivity. Investors should treat it as a tactical tool, not a long-term hold, given its erosion of value over time.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Direxion Daily 20 Year Treasury Bull 3X Shares
TMF is a leveraged ETF that seeks to provide 300% (3x) of the daily performance of the ICE U.S. Treasury 20+ Year Bond Index. It is a tactical instrument used by sophisticated traders to capitalize on declining interest rates or to hedge against equity market volatility. Due to its daily reset mechanism and high expense ratio, TMF is structurally designed for short-term speculation rather than long-term buy-and-hold investing.
Read more on TMF →
